[Drug evaluation: new requirements and perspectives]
Antonio Addis1, Francesca Rocchi
1Agenzia Italiana del Farmaco, Ministero della Salute, Roma.
Recenti Progressi in Medicina
|January 27, 2007
Summary
European and international drug regulatory agencies struggle with efficient processes, leading to drug withdrawals and uncontrolled costs. Italy
Area of Science:
- Pharmacovigilance and Drug Regulation
- Health Policy and Management
Context:
- Current drug regulatory systems face challenges in efficiently guiding clinical practice.
- Issues include premature drug withdrawals, compromised independence, and escalating pharmaceutical expenditures.
- Existing approval processes often rely on minimum efficacy standards and rapid registration, potentially compromising real-world safety and efficacy assessment.
Purpose:
- To address the limitations of current drug regulatory frameworks.
- To introduce an innovative regulatory approach aligning with European standards.
- To enhance drug safety, efficacy evaluation, and rational drug utilization.
Summary:
- The Italian Medicines Agency (AIFA) has implemented a new regulatory model.
- This model promotes appropriate drug use through real-world data analysis.
- It emphasizes independent drug research and disseminates unbiased drug information to healthcare professionals.
Impact:
- The Italian approach aims to bridge the gap between regulatory policy and clinical practice.
- It fosters rational drug use and strengthens research, vigilance, and information dissemination.
- This model seeks to improve public health outcomes through more effective drug regulation.
Related Concept Videos
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
22
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
22
01:14Drug Dissolution: Requirements and Profile Comparison
310
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
310
01:25Drug Regulation
3.1K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.1K
01:11Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
01:28Preclinical Development: Overview
6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
01:26Drug Discovery: Overview
12.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.1K